CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).
Br J Haematol
; 171(2): 210-214, 2015 Oct.
Article
en En
| MEDLINE
| ID: mdl-26085061
Mutations of CSNK1A1, a gene mapping to the commonly deleted region of the 5q- syndrome, have been recently described in patients with del(5q) myelodysplastic syndromes (MDS). Haploinsufficiency of Csnk1a1 in mice has been shown to result in ß-catenin activation and expansion of haematopoietic stem cells (HSC). We have screened a large cohort of 104 del(5q) MDS patients and have identified mutations of CSNK1A1 in five cases (approximately 5%). We have shown up-regulation of ß-catenin target genes in the HSC of patients with del(5q) MDS. Our data further support a central role of CSNK1A1 in the pathogenesis of MDS with del(5q).
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Br J Haematol
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Reino Unido